🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Adenocarcinoma (NOS)

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma NCT04634357Phase 1, Phase 24 sites📍 Los Angeles📍 Orange📍 San Francisco Eureka Therapeutics Inc. · Tests: ET140203 T Cells 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) NCT06896188Phase 11 site📍 Pittsburgh Anwaar Saeed · Tests: Retifanlimab, Chemotherapy, 9-ING-41 Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation NCT07489820NA5 sites📍 Amiens📍 Angers📍 La Roche-sur-Yon Centre Hospitalier Departemental Vendee · Tests: Direct perineal skin suturing with negative pressure wound therapy (PICO 7®), Direct perineal skin suture DESTINY-PANTUMOUR04 NCT07124000n/a18 sites📍 Birmingham📍 Bullhead City📍 Casa Grande AstraZeneca · Tests: Trastuzumab deruxtecan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy